Event Type: Earnings Conference Call for Analysts and Investors following the announcement of Q2 FY27 financial results.
Date and Time: Wednesday, November 4, 2026, at 16:00 hrs IST.
Purpose: Discussion of unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
Timing Relative to Earnings: The conference call will be held after the Board meeting scheduled for the same day (November 4, 2026) to approve the financial results.
Management Participants: Not explicitly named in the disclosure, but the conference call will feature "the management team" of Biocon Limited. Prashant Nair (Investor Relations) is listed as the contact for further information.
Availability of Materials: An audio recording will be made available before the next trading day or within 24 hours from the end of the call, whichever is earlier. A video recording will be made available within 48 hours from the end of the call. A transcript of the conference call will be made available within 5 working days of its conclusion. All materials will be hosted on the Company website under Investors > Financial Information > Earnings Call Recordings/Transcripts.
UPSI Statement: The document includes a standard 'Safe Harbor' statement noting that forward-looking statements made during the call involve known and unknown risks and uncertainties. It does not explicitly state that no Unpublished Price Sensitive Information (UPSI) will be shared.
Additional Notes Section
The intimation letter to the exchanges includes an enclosure with the conference call details.
No financial data or performance figures were disclosed in this announcement. The document solely pertains to the scheduling of the board meeting and the subsequent investor call.
The call will be conducted over the Zoom platform. A registration link is provided (denoted as "Click here" in the source).
The trading window for dealing in the company's securities has been closed from October 1, 2026, and will reopen on November 7, 2026.
